drugset
drugset / Trial / NCT00002139

Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.

NCT00002139 ↗

Phase 1 Completed Pfizer
Open-labelTreatment

Summary

To compare the uptake of azithromycin in white cells relative to plasma concentrations in HIV-infected patients.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule — Oral

Indications

HIV infectious disease bacterial infectious disease